Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Control Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Florence

About this trial

Chronic migraine is a disabling type of migraine and is often resistant to treatment. Non-pharmacological interventions have been investigated as potential treatment although, unfortunately, the literature on their efficacy is poor and showed mixed results. Well-Being Therapy (WBT) is a brief psychotherapy which has shown efficacy in decreasing the relapse rates of depression in adults, in generalized anxiety disorder and in cyclothymia. It can be implemented to empower psychological well-being. The aim of the present study is to test the efficacy of WBT in a sample of patients with chronic migraine to verify if it reduces the disability due to migraine and distress, it increases the psychological well-being as well as the level of euthymia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

able and interested in participating to the present research project, as proved by signed Informed consent;

18-65 years of age;

Italian mother tongue;

diagnosis of chronic migraine according to the International Classification of Headache Disorders. Thus, presenting specific features (i.e., unilateral and pulsating pain of moderate or severe intensity, which is aggravated or precipitated by routine physical activities and is combined with nausea and/or vomiting, photophobia, and phonophobia) and migraine headache on ≥ 15 days per month;

Disqualifiers

diagnosis of medication overuse headache;

co-occurrence of psychiatric disorder(s) according to the Diagnostic and Statistical Manual of mental disorders (DSM) 5th edition as diagnosed via the MINI International Neuropsychiatric Interview;

co-occurrence of chronic unstable medical conditions;

being pregnant or lactating;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Well-Being Therapy

    Behavioral

    Session 1: identifying and setting episodes of wellbeing into situational context. Session 2: identifying interfering thoughts and behaviors. Session 3: illustrating autonomy, reflecting and practicing it. Session 4: illustrating environmental mastery, reflecting and practicing it. Session 5: illustrating positive relations with others, reflecting and practicing it. Session 6: illustrating personal growth, reflecting and practicing it. Session 7: illustrating self-acceptance, reflecting and practicing it. Session 8: illustrating purpose in life, reflecting and practicing it.

  • Control condition

    Other intervention

    Session 1: illustrating the concept of lifestyle and well-being. Session 2 and session 3: illustrating healthy eating and steps to healthy eating. Session 4: illustrating physical exercise and how it promotes health. Session 5: illustrating smoking and tobacco and how they can damage health. Session 6: illustrating alcohol and how it can damage health. Session 7: illustrating drugs misuse and how it can damage health. Session 8: illustrating sexual health. No access to specific WBT ingredients will be allowed.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Well-being therapyExperimental treatment 1 intervention
Group B: Control conditionPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

disability due to migraine

level of disability due to migraine assessed via the Migraine Disability Assessment Score (score from 0 to \>21, for total score \> 6 disability is clinically relevant)

Time frame
from baseline to 3-month follow up
2

frequency of migraine attacks

frequency of migraine attacks assessed via a daily self-report headache diary (higher the frequency, higher the severity of migraine)

Time frame
from baseline to 3-month follow up
3

duration of migraine attacks

duration of migraine attacks assessed via a daily self-report headache diary (higher the duration, higher the severity of migraine)

Time frame
from baseline to 3-month follow up
4

intensity of migraine attacks

intensity of migraine attacks assessed via a daily self-report headache diary (higher the intensity, higher the severity of migraine)

Time frame
from baseline to 3-month follow up

Secondary outcomes

1

level of anxiety and depression

the level of anxiety and depression will be assessed via the Symptom Questionnaire (total score from 0 to 92, higher is the total score and worse is the symptomatology)

Time frame
from baseline to 3-month follow up
2

level of psychological well-being

assessed via the World Health Organization-Five Well-Being Index (WHO 5) (total score from 0 to 25, higher total score means higher quality of life)

Time frame
from baseline to 3-month follow up
3

level of psychological well-being

assessed via Psychological Well-Being Questionnaire (PWB) (total score from 84 to 504, higher score corresponds to higher psychological well-being)

Time frame
from baseline to 3-month follow up
4

the level of euthymia

the level of euthymia will be assessed via the euthymia scale (total score from 0 to 10, higher score corresponds to higher level of euthymia)

Time frame
from baseline to 3-month follow up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.